Exodus Point Capital Management, LP Chimerix Inc Transaction History

Exodus Point Capital Management, LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$1.81 - $2.76 $128,640 - $196,158	-71,072 Closed	0 $0
Q2 2022 Aug 19, 2022	BUY	$1.34 - $5.34 $52,400 - $208,820	39,105 Added 122.33%	71,072 $148,000
Q1 2022 May 13, 2022	BUY	$4.58 - $6.8 $146,408 - $217,375	31,967 New	31,967 $146,000
Q3 2021 Nov 15, 2021	SELL	$5.94 - $8.75 $123,819 - $182,393	-20,845 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$7.54 - $9.79 $157,171 - $204,072	20,845 New	20,845 $167,000
Q3 2020 Nov 16, 2020	SELL	$2.3 - $3.72 $31,171 - $50,417	-13,553 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$1.33 - $3.63 $18,025 - $49,197	13,553 New	13,553 $42,000

36.8M

72.2K

169K

Ticker CMRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,622,896
Market Cap $85M
Description
Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.